Gastric or Duodenal Ulcers Clinical Trial
Official title:
Special Drug Use Surveillance of Takecab Tablets for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"
The purpose of this survey is to investigate the safety and effectiveness of long-term administration of vonoprazan tablets for up to 12 months in the routine clinical setting in patients receiving low-dose aspirin.
The drug being tested in this survey is called vonoprazan. Vonoprazan is being tested to
treat people who have gastric or duodenal ulcers.
This survey will look at the safety and effectiveness of long-term administration of
vonoprazan tablets for up to 12 months in the routine clinical setting in patients receiving
low-dose aspirin.
The survey will enroll approximately 1,000 participants.
- Vonoprazan 10 mg
This multi-center observational survey will be conducted in Japan.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02099708 -
Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs
|
N/A | |
| Completed |
NCT05959486 -
A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fasting Conditions in Healthy Adult Volunteers
|
Phase 1 | |
| Completed |
NCT02099682 -
Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin
|
N/A |